Report Content
Chapter 1 Methodology & Scope
1.1 Methodology
1.2 Market definitions
1.3 Market estimation & forecast parameters
1.4 Data Sources
1.4.1 Primary
1.4.2 Secondary
1.4.2.1 Paid Sources
1.4.2.2 Public Sources
Chapter 2 Executive Summary
2.1 Finasteride industry 3600 synopsis, 2015 - 2026
2.1.1 Business Trend
2.1.2 Regional trends
2.1.3 Product trends
2.1.4 Application trends
Chapter 3 Finasteride Market Industry Insights
3.1 Industry Segmentation
3.2 Industry landscape, 2015- 2026
3.3 Industry ecosystem analysis
3.3.1 Raw materials
3.3.2 Manufacturers
3.3.3 Distributors
3.4 Vendor matrix
3.4.1 Distribution channel analysis
3.4.2 Profit margin trend
3.5 Pricing analysis
3.5.1 Cost structure analysis, 2019
3.6 Regulatory landscape
3.6.1 France
3.6.2 U.S.
3.6.3 China
3.6.4 Key regulations for finasteride
3.7 Industry Impact Forces
3.7.1 Growth drivers
3.7.1.1 Rising cases of prostate cancer
3.7.1.2 Trend for hair care products will prompt consumers to rely on hair medication
3.7.1.3 Growing consumer spending on hair care products accompanied by expanding distribution channel
3.7.2 Industry pitfalls & challenges
3.7.2.1 Possible side effects associated with the finasteride tablets
3.8 Innovation & sustainability
3.9 Growth potential analysis, 2019
3.9.1 Emerging business models
3.10 Porter's analysis
3.11 Competitive Landscape, 2019
3.11.1 Top player overview
3.11.2 Strategy Dashboard
3.12 PESTEL analysis
Chapter 4 Global Finasteride Market, By Product
4.1 Key product trends
4.2 1mg
4.2.1 Global 1mg finasteride market,2015-2026, (Tons) (USD Thousand)
4.2.2 Global 1mg finasteride market by region,2015-2026, (Tons) (USD Thousand)
4.3 5mg
4.3.1 Global 5mg finasteride market, 2015-2026, (Tons) (USD Thousand)
4.3.2 Global 5mg finasteride market by region, 2015-2026, (Tons) (USD Thousand)
Chapter 5 Global Finasteride Market, By Application
5.1 Key application trends
5.2 Prostate treatment
5.2.1 Global finasteride market from prostate treatment application, 2015-2026, (Tons) (USD Thousand)
5.2.2 Global finasteride market from prostate treatment application by region, 2015-2026, (Tons) (USD Thousand)
5.2.3 Prostate Enlargement
5.2.3.1 Global finasteride market from prostate enlargement application, 2015-2026, (Tons) (USD Thousand)
5.2.3.2 Global finasteride market from prostate enlargement application by region, 2015-2026, (Tons) (USD Thousand)
5.2.4 Prostate cancer
5.2.4.1 Global finasteride market from prostate cancer application, 2015-2026, (Tons) (USD Thousand)
5.2.4.2 Global finasteride market from prostate cancer application by region, 2015-2026, (Tons) (USD Thousand)
5.2.5 Hormone therapy (transgender women)
5.2.5.1 Global finasteride market from hormone therapy (transgender women) application, 2015-2026, (Tons) (USD Thousand)
5.2.5.2 Global finasteride market from hormone therapy (transgender women) application by region, 2015-2026, (Tons) (USD Thousand)
5.3 Hair treatment
5.3.1 Global finasteride market from hair treatment application, 2015-2026, (Tons) (USD Thousand)
5.3.2 Global finasteride market from hair treatment application by region, 2015-2026, (Tons) (USD Thousand)
5.3.3 Scalp hair loss
5.3.3.1 Global finasteride market from scalp hair loss application, 2015-2026, (Tons) (USD Thousand)
5.3.3.2 Global finasteride market from scalp hair loss application by region, 2015-2026, (Tons) (USD Thousand)
5.3.4 Excessive hair growth
5.3.4.1 Global finasteride market from excessive hair growth application, 2015-2026, (Tons) (USD Thousand)
5.3.4.2 Global finasteride market from excessive hair growth application by region, 2015-2026, (Tons) (USD Thousand)
Chapter 6 Global Finasteride Market, By Region
6.1 Key regional trends
6.2 North America
6.2.1 North America finasteride market, 2015-2026, (Tons) (USD Thousand)
6.2.2 North America finasteride market by product, 2015-2026, (Tons) (USD Thousand)
6.2.3 North America finasteride market by application, 2015-2026, (Tons) (USD Thousand)
6.2.4 U.S.
6.2.4.1 U.S. finasteride market, 2015-2026, (Tons) (USD Thousand)
6.2.4.2 U.S. finasteride market by product, 2015-2026, (Tons) (USD Thousand)
6.2.4.3 U.S. finasteride market by application, 2015-2026, (Tons) (USD Thousand)
6.2.5 Canada
6.2.5.1 Canada finasteride market, 2015-2026, (Tons) (USD Thousand)
6.2.5.2 Canada finasteride market by product, 2015-2026, (Tons) (USD Thousand)
6.2.5.3 Canada finasteride market by application, 2015-2026, (Tons) (USD Thousand)
6.2.6 Mexico
6.2.6.1 Mexico finasteride market, 2015-2026, (Tons) (USD Thousand)
6.2.6.2 Mexico finasteride market by product, 2015-2026, (Tons) (USD Thousand)
6.2.6.3 Mexico finasteride market by application, 2015-2026, (Tons) (USD Thousand)
6.3 Europe
6.3.1 Europe finasteride market, 2015-2026, (Tons) (USD Thousand)
6.3.2 Europe finasteride market by product, 2015-2026, (Tons) (USD Thousand)
6.3.3 Europe finasteride market by application, 2015-2026, (Tons) (USD Thousand)
6.3.4 Germany
6.3.4.1 Germany finasteride market, 2015-2026, (Tons) (USD Thousand)
6.3.4.2 Germany finasteride market by product, 2015-2026, (Tons) (USD Thousand)
6.3.4.3 Germany finasteride market by application, 2015-2026, (Tons) (USD Thousand)
6.3.5 UK
6.3.5.1 UK finasteride market, 2015-2026, (Tons) (USD Thousand)
6.3.5.2 UK finasteride market by product, 2015-2026, (Tons) (USD Thousand)
6.3.5.3 UK finasteride market by application, 2015-2026, (Tons) (USD Thousand)
6.3.6 France
6.3.6.1 France finasteride market, 2015-2026, (Tons) (USD Thousand)
6.3.6.2 France finasteride market by product, 2015-2026, (Tons) (USD Thousand)
6.3.6.3 France finasteride market by application, 2015-2026, (Tons) (USD Thousand)
6.3.7 Italy
6.3.7.1 Italy finasteride market, 2015-2026, (Tons) (USD Thousand)
6.3.7.2 Italy finasteride market by product, 2015-2026, (Tons) (USD Thousand)
6.3.7.3 Italy finasteride market by application, 2015-2026, (Tons) (USD Thousand)
6.3.8 Spain
6.3.8.1 Spain finasteride market, 2015-2026, (Tons) (USD Thousand)
6.3.8.2 Spain finasteride market by product, 2015-2026, (Tons) (USD Thousand)
6.3.8.3 Spain finasteride market by application, 2015-2026, (Tons) (USD Thousand)
6.3.9 Poland
6.3.9.1 Poland finasteride market, 2015-2026, (Tons) (USD Thousand)
6.3.9.2 Poland finasteride market by product, 2015-2026, (Tons) (USD Thousand)
6.3.9.3 Poland finasteride market by application, 2015-2026, (Tons) (USD Thousand)
6.3.10 Russia
6.3.10.1 Russia finasteride market, 2015-2026, (Tons) (USD Thousand)
6.3.10.2 Russia finasteride market by product, 2015-2026, (Tons) (USD Thousand)
6.3.10.3 Russia finasteride market by application, 2015-2026, (Tons) (USD Thousand)
6.4 Asia Pacific (APAC)
6.4.1 APAC finasteride market, 2015-2026, (Tons) (USD Thousand)
6.4.2 APAC finasteride market by product, 2015-2026, (Tons) (USD Thousand)
6.4.3 APAC finasteride market by application, 2015-2026, (Tons) (USD Thousand)
6.4.4 China
6.4.4.1 China finasteride market, 2015-2026, (Tons) (USD Thousand)
6.4.4.2 China finasteride market by product, 2015-2026, (Tons) (USD Thousand)
6.4.4.3 China finasteride market by application, 2015-2026, (Tons) (USD Thousand)
6.4.5 India
6.4.5.1 India finasteride market, 2015-2026, (Tons) (USD Thousand)
6.4.5.2 India finasteride market by product, 2015-2026, (Tons) (USD Thousand)
6.4.5.3 India finasteride market by application, 2015-2026, (Tons) (USD Thousand)
6.4.6 Japan
6.4.6.1 Japan finasteride market, 2015-2026, (Tons) (USD Thousand)
6.4.6.2 Japan finasteride market by product, 2015-2026, (Tons) (USD Thousand)
6.4.6.3 Japan finasteride market by application, 2015-2026, (Tons) (USD Thousand)
6.4.7 South Korea
6.4.7.1 South Korea finasteride market, 2015-2026, (Tons) (USD Thousand)
6.4.7.2 South Korea finasteride market by product, 2015-2026, (Tons) (USD Thousand)
6.4.7.3 South Korea finasteride market by application, 2015-2026, (Tons) (USD Thousand)
6.4.8 Australia
6.4.8.1 Australia finasteride market, 2015-2026, (Tons) (USD Thousand)
6.4.8.2 Australia finasteride market by product, 2015-2026, (Tons) (USD Thousand)
6.4.8.3 Australia finasteride market by application, 2015-2026, (Tons) (USD Thousand)
6.4.9 Malaysia
6.4.9.1 Malaysia finasteride market, 2015-2026, (Tons) (USD Thousand)
6.4.9.2 Malaysia finasteride market by product, 2015-2026, (Tons) (USD Thousand)
6.4.9.3 Malaysia finasteride market by application, 2015-2026, (Tons) (USD Thousand)
6.5 Latin America (LATAM)
6.5.1 LATAM finasteride market, 2015-2026, (Tons) (USD Thousand)
6.5.2 LATAM finasteride market by product, 2015-2026, (Tons) (USD Thousand)
6.5.3 LATAM finasteride market by application, 2015-2026, (Tons) (USD Thousand)
6.5.4 Brazil
6.5.4.1 Brazil finasteride market, 2015-2026, (Tons) (USD Thousand)
6.5.4.2 Brazil finasteride market by product, 2015-2026, (Tons) (USD Thousand)
6.5.4.3 Brazil finasteride market by application, 2015-2026, (Tons) (USD Thousand)
6.5.5 Argentina
6.5.5.1 Argentina finasteride market, 2015-2026, (Tons) (USD Thousand)
6.5.5.2 Argentina finasteride market by product, 2015-2026, (Tons) (USD Thousand)
6.5.5.3 Argentina finasteride market by application, 2015-2026, (Tons) (USD Thousand)
6.6 Middle East & Africa (MEA)
6.6.1 MEA finasteride market, 2015-2026, (Tons) (USD Thousand)
6.6.2 MEA finasteride market by product, 2015-2026, (Tons) (USD Thousand)
6.6.3 MEA finasteride market by application, 2015-2026, (Tons) (USD Thousand)
6.6.4 Saudi Arabia
6.6.4.1 Saudi Arabia finasteride market, 2015-2026, (Tons) (USD Thousand)
6.6.4.2 Saudi Arabia finasteride market by product, 2015-2026, (Tons) (USD Thousand)
6.6.4.3 Saudi Arabia finasteride market by application, 2015-2026, (Tons) (USD Thousand)
6.6.5 UAE
6.6.5.1 UAE finasteride market, 2015-2026, (Tons) (USD Thousand)
6.6.5.2 UAE finasteride market by product, 2015-2026, (Tons) (USD Thousand)
6.6.5.3 UAE finasteride market by application, 2015-2026, (Tons) (USD Thousand)
6.6.6 South Africa
6.6.6.1 South Africa finasteride market, 2015-2026, (Tons) (USD Thousand)
6.6.6.2 South Africa finasteride market by product, 2015-2026, (Tons) (USD Thousand)
6.6.6.3 South Africa finasteride market by application, 2015-2026, (Tons) (USD Thousand)
Chapter 7 Company Profiles
7.1 Merck & Co., Inc.
7.1.1 Business Overview
7.1.2 Financial Data
7.1.3 Product Landscape
7.1.4 SWOT Analysis
7.2 Novartis AG
7.2.1 Business Overview
7.2.2 Financial Data
7.2.3 Product Landscape
7.2.4 SWOT Analysis
7.3 Teva Pharmaceutical Industries Ltd
7.3.1 Business Overview
7.3.2 Financial Data
7.3.3 Product Landscape
7.3.4 SWOT Analysis
7.4 Cipla
7.4.1 Business Overview
7.4.2 Financial Data
7.4.3 Product Landscape
7.4.4 SWOT Analysis
7.5 RelonChem
7.5.1 Business Overview
7.5.2 Financial Data
7.5.3 Product Landscape
7.5.4 Strategic Outlook
7.5.5 SWOT Analysis
7.6 Dr. Reddy
7.6.1 Business Overview
7.6.2 Financial Data
7.6.3 Product Landscape
7.6.4 Strategic Outlook
7.6.5 SWOT Analysis
7.7 Henan Topfond
7.7.1 Business Overview
7.7.2 Financial Data
7.7.3 Product Landscape
7.7.4 Strategic Outlook
7.7.5 SWOT Analysis
7.8 Zhejiang CONBA Pharmaceutical
7.8.1 Business Overview
7.8.2 Financial Data
7.8.3 Product Landscape
7.8.4 Strategic Outlook
7.8.5 SWOT Analysis
7.9 Shandong Renhetang Pharmaceutical
7.9.1 Business Overview
7.9.2 Financial Data
7.9.3 Product Landscape
7.9.4 Strategic Outlook
7.9.5 SWOT Analysis
7.10 Guangdong Eashu Pharmacetical
7.10.1 Business Overview
7.10.2 Financial Data
7.10.3 Product Landscape
7.10.4 Strategic Outlook
7.10.5 SWOT Analysis
